Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery

Combining Dynamic Biosensors’ Innovative Technologies with Bruker’s High-Performance SPR Portfolio to Establish a Leading Biosensors Business

07-Oct-2024 - Bruker Corporation announced the acquisition of Dynamic Biosensors GmbH, a pioneering company known for its breakthroughs in biosensor development, which is based in Munich, Germany. This acquisition strengthens Bruker’s biophysical portfolio for the analysis of molecular interactions and ...

eMolecules acquires Synple Chem AG

"We are thrilled to welcome the highly reputable and talented Synple team into eMolecules"

26-Sep-2024 - eMolecules, Inc. announced that it has acquired Synple Chem AG ("Synple"). Synple was founded in 2016 as a Spin-off from ETH Zürich. Synple specializes in automated chemical synthesis systems and solutions for small molecules drug discovery customers. WithSynple's virtual compound library, which ...

PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes

16-Sep-2024 - PhoreMost Ltd. announced it has added USD $12 million to its Series B financing, bringing the total raised to over $50 million. The additional investment was led by Parkwalk Advisors, the largest growth EIS fund manager, with participation from existing investors BGF, Dr Jonathan Milner, Amadeus ...

Efficiency boost for drug discovery

Insilico Medicine and Inimmune achieved collaboration to revolutionize immunotherapy with AI-driven drug discovery

12-Sep-2024 - Insilico Medicine announced that the company has achieved a groundbreaking collaboration with Inimmune, which will utilize Chemistry42, Insilico's proprietary generative artificial intelligence (AI) technology to accelerate the discovery and development of next-generation ...

Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery

Partnerships with BenevolentAI and Exscientia to drive accelerated drug discovery with higher probability of success

20-Sep-2023 - Merck announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery capabilities, further advancing the company’s research efforts. The partnerships, with BenevolentAI, London, U.K., and Exscientia, Oxford, U.K., ...

Investment Plan for Europe: Successful launch of Tech Transfer Fund “KHAN-I”

13-Sep-2019 - Khanu Management GmbH (Khanu), a drug discovery focused fund management team, announces the successful launch of KHAN Technology Transfer Fund I GmbH & Co KG (KHAN-I), based in Dortmund, Germany. The European Investment Fund (EIF, Luxemburg), the Austria Wirtschaftsservice GmbH (Vienna, Austria) ...

Drug-induced cellular membrane complexes induce cancer cell death

New sub-cellular complex discovered

13-Feb-2019 - Old molecules and new complexes: researchers at Hollings Cancer Center at the Medical University of South Carolina (MUSC) have discovered cell membrane complexes called ceramidosomes that may be a new target for drugs to kill cancer cells. This discovery began while figuring out the unexpected ...

New insight into cell receptors opens the way for tailored cancer drugs

12-Feb-2019 - New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer. This according to researchers at Sweden's Karolinska Institutet and Uppsala University, ...

Structure of virus that infects bacteria in hot springs is revealed

06-Feb-2019 - Scientists have revealed the structure of a virus infecting bacteria that thrive in 160-degree hot springs in places like Yellowstone National Park in Wyoming. The discovery could lead to better targeted delivery of drugs into cells and new DNA sequencing technology, according to a study by ...

University spinout receives £1.2 million to tackle antimicrobial resistance

04-Feb-2019 - Amprologix Limited, a University of Plymouth spinout company, has won a £1.2 million contract from the Department for Health and Social Care to accelerate development and scale up its lead antibiotic candidate to tackle antimicrobial resistant MRSA and related superbugs. Amprologix was ...